Abstract:Atherosclerosis is a chronic pathological condition featured by accumulation of lipids and fibrous elements in the artery. Atherosclerosis remains as the primary cause of cardiovascular diseases and agents that effectively intervenes the development of atherosclerosis are still needed. Panax notoginseng has been extensively used as therapeutic agent in Asia to treat cardiovascular disorders. Panax notoginseng saponins (PNS) is the major class of active components of Panax notoginseng. PNS has been reported to possess anti-atherosclerotic effect. However, which component of PNS is responsible for this effect remains unknown. The current study evaluated the effects of a component unique to PNS, PNS-R1, on atherosclerosis in ApoE-/- mouse model. Histological examination revealed that the extent of atherosclerotic lesion was significantly alleviated in PNS-R1-treated ApoE-/- mice compared to that from the ApoE-/- controls. Meanwhile, PNS-R1 treatment significantly reduced the level of oxidative stress in the atherosclerotic lesion, which was prominently enhanced in ApoE-/- controls. This effect on oxidative stress was corroborated by increased serum level of GSH and SOD and decreased level of MDH in PNS-treated mice. Furthermore, PNS-R1 treatment significantly decreased the levels of total cholesterol, triglycerides and increased the level of HDL without affecting the level of LDL, suggesting an effect of PNS-R1 on lipid metabolism, which could in part contribute to its action in attenuating atherosclerosis. Additionally, the levels of inflammatory factors including IL-2, IL-6, TNF-α, γ-IFN and ox-LDL were markedly reduced in PNS-R1-treated mice compared to that from the ApoE-/- controls, demonstrating a significant anti-inflammatory effect of PNS-R1 in the development of atherosclerosis. Expression of microRNAs known to be involved in the pathogenesis of atherosclerosis was further evaluated and showed that PNS-R1 treatment led to a significant reduction in the expression of miR-122, miR-132 and miR-155. Collectively, our results provided for the first time the experimental evidence supporting the anti-atherosclerotic effects of PNS-R1, which could be a promising therapeutic agent treating atherosclerosis.

Notoginsenoside R1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model.

Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF

Ginsenoside Rb-1 Enhances Plaque Stability And Inhibits Adventitial Vasa Vasorum Via The Modulation Of Mir-33 And Pedf

Notoginsenoside R1-Protocatechuic Aldehyde Reduces Vascular Inflammation and Calcification Through Increasing the Release of Nitric Oxide to Inhibit TGFβR1-YAP/TAZ Pathway in Vascular Smooth Muscle Cells

Notoginsenoside R1 activates the Ang2/Tie2 pathway to promote angiogenesis.

Notoginsenoside R1 Activates the Ang2/Tie2 Pathway to Promote Angiogenesis

Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic Aldehyde Reduces Atherosclerosis and Attenuates Low-Shear Stress-Induced Vascular Endothelial Cell Dysfunction

Notoginsenoside R1 Inhibits Oxidized Low-Density Lipoprotein Induced Inflammatory Cytokines Production in Human Endothelial EA.hy926 Cells.

Abstract 451: PNS-R1 Attenuates the Development of Atherosclerosis in ApoE-Deficient Mouse Model

Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.

Panax Notoginseng Saponins Inhibits Atherosclerotic Plaque Angiogenesis by Down-Regulating Vascular Endothelial Growth Factor and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Subunit 4 Expression.

Retraction Note To: Ginsenoside-Rg1 Enhances Angiogenesis and Ameliorates Ventricular Remodeling in a Rat Model of Myocardial Infarction

Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis

Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic aldehyde attenuates low shear stress-induced vascular endothelial cell dysfunction

Ginsenoside-Rd, A Purified Component from Panax Notoginseng Saponins, Prevents Atherosclerosis in Apoe Knockout Mice

Retracted: Ginsenoside-Rg1 Enhances Angiogenesis And Ameliorates Ventricular Remodeling In A Rat Model Of Myocardial Infarction (Retracted Article. See Vol. 91, Pg. 645, 2013)

Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway

Effect of Notoginsenoside R1 on Hepatic Microcirculation Disturbance Induced by Gut Ischemia and Reperfusion